vs
Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Nomad Foods Ltd (NOMD). Click either name above to swap in a different company.
Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.2B vs $834.9M, roughly 1.5× Nomad Foods Ltd). On growth, Nomad Foods Ltd posted the faster year-over-year revenue change (-2.6% vs -74.7%).
Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.
Nomad Foods is the largest frozen food company in Europe, whose popular brands include Birds Eye, Ledo, Iglo, Findus, and Frikom. The company manufactures, sells and distributes a range of frozen food products across 22 European markets, with its headquarters in the United Kingdom. The most popular products in Nomad Foods’ portfolio include fish fingers, creamed spinach, peas and chicken. Nomad Foods is listed on the New York Stock Exchange trading under the ticker “NOMD”.
ALHC vs NOMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $834.9M |
| Net Profit | $11.4M | — |
| Gross Margin | — | 25.6% |
| Operating Margin | — | 9.1% |
| Net Margin | 0.9% | — |
| Revenue YoY | -74.7% | -2.6% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.0B | $834.9M | ||
| Q3 25 | $993.7M | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $926.9M | — | ||
| Q4 24 | $701.2M | $856.9M | ||
| Q3 24 | $692.4M | — | ||
| Q2 24 | $681.3M | — |
| Q1 26 | $11.4M | — | ||
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $3.7M | — | ||
| Q2 25 | $15.7M | — | ||
| Q1 25 | $-9.1M | — | ||
| Q4 24 | $-31.1M | $55.5M | ||
| Q3 24 | $-26.4M | — | ||
| Q2 24 | $-24.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 25.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 28.5% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | -1.0% | 9.1% | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | -0.6% | — | ||
| Q4 24 | -3.2% | 11.5% | ||
| Q3 24 | -2.8% | — | ||
| Q2 24 | -2.7% | — |
| Q1 26 | 0.9% | — | ||
| Q4 25 | -1.1% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | -1.0% | — | ||
| Q4 24 | -4.4% | 6.5% | ||
| Q3 24 | -3.8% | — | ||
| Q2 24 | -3.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $0.02 | — | ||
| Q2 25 | $0.07 | — | ||
| Q1 25 | $-0.05 | — | ||
| Q4 24 | $-0.15 | — | ||
| Q3 24 | $-0.14 | — | ||
| Q2 24 | $-0.13 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $705.6M | — |
| Total DebtLower is stronger | — | $2.5B |
| Stockholders' EquityBook value | $206.9M | $2.7B |
| Total Assets | $1.3B | $6.8B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $705.6M | — | ||
| Q4 25 | $604.2M | — | ||
| Q3 25 | $644.1M | — | ||
| Q2 25 | $503.8M | — | ||
| Q1 25 | $479.5M | — | ||
| Q4 24 | $470.6M | — | ||
| Q3 24 | $381.0M | — | ||
| Q2 24 | $363.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $323.2M | $2.5B | ||
| Q3 25 | $322.7M | — | ||
| Q2 25 | $322.3M | — | ||
| Q1 25 | $321.9M | — | ||
| Q4 24 | $321.4M | $2.4B | ||
| Q3 24 | $212.0M | — | ||
| Q2 24 | $211.7M | — |
| Q1 26 | $206.9M | — | ||
| Q4 25 | $179.3M | $2.7B | ||
| Q3 25 | $161.9M | — | ||
| Q2 25 | $141.0M | — | ||
| Q1 25 | $108.1M | — | ||
| Q4 24 | $99.9M | $2.9B | ||
| Q3 24 | $114.5M | — | ||
| Q2 24 | $123.7M | — |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.1B | $6.8B | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $895.6M | — | ||
| Q4 24 | $782.1M | $6.9B | ||
| Q3 24 | $692.3M | — | ||
| Q2 24 | $716.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.80× | 0.92× | ||
| Q3 25 | 1.99× | — | ||
| Q2 25 | 2.29× | — | ||
| Q1 25 | 2.98× | — | ||
| Q4 24 | 3.22× | 0.82× | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.71× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $128.7M | $357.2M |
| Free Cash FlowOCF − Capex | — | $272.4M |
| FCF MarginFCF / Revenue | — | 32.6% |
| Capex IntensityCapex / Revenue | — | 10.2% |
| Cash ConversionOCF / Net Profit | 11.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.3B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $128.7M | — | ||
| Q4 25 | $-50.4M | $357.2M | ||
| Q3 25 | $144.6M | — | ||
| Q2 25 | $29.1M | — | ||
| Q1 25 | $16.6M | — | ||
| Q4 24 | $-8.7M | $470.2M | ||
| Q3 24 | $26.2M | — | ||
| Q2 24 | $23.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-55.4M | $272.4M | ||
| Q3 25 | $139.1M | — | ||
| Q2 25 | $21.1M | — | ||
| Q1 25 | $8.4M | — | ||
| Q4 24 | $-18.0M | $383.5M | ||
| Q3 24 | $16.9M | — | ||
| Q2 24 | $11.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | -5.5% | 32.6% | ||
| Q3 25 | 14.0% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | -2.6% | 44.8% | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 1.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 10.2% | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 1.3% | 10.1% | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.7% | — |
| Q1 26 | 11.27× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 38.77× | — | ||
| Q2 25 | 1.86× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 8.47× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
